Postinduction Supportive Care of Pediatric Acute Myelocytic Leukemia: Should Patients be Kept in the Hospital?. (29th September 2014)

• Record Type: Journal Article
• Authors: Inoue, Susumu; Khan, Isra'a; Mushtaq, Rao; Carson, Dawn; Saah, Elna; Onwuzurike, Nkechi
• Other Names: Cilloni Daniela Academic Editor.
• Is Part Of: Leukemia research and treatment. Volume 2014(2014)
• Publication Date: 2014-09-29
• Subjects: Leukemia -- Periodicals; Leukemia -- Treatment -- Periodicals; Leukemia; Leukemia -- therapy; Leukemia; Leukemia -- Treatment; Leukemia -- Periodicals; Leukemia -- Treatment -- Periodicals; Leukemia -- therapy -- Periodicals; Electronic journals; Periodicals; Periodicals; 616.99419
• DOI: 10.1155/2014/592379
• Languages: English
• ISSNs: 2090-3219

Abstract

Abstract : Children with AML become profoundly neutropenic while they undergo remission induction chemotherapy. It is unknown whether these children should be kept in the hospital while they are severely neutropenic to prevent life-threatening complications associated with neutropenia and reduce fatality. We at our institution routinely discharge patients after completing remission induction chemotherapy in the presence of profound neutropenia, unless it is clinically contraindicated. We reviewed all AML patients who were consecutively treated at our hospital from 1989 to 2011. Thirteen patients were electively discharged after completion of induction I chemotherapy. Of the 13, 4 died due to relapse or complications of stem cell transplants (not due to neutropenia related complications). Another eight are long term survivors. In this very small series, discharge from the hospital even though patients were severely neutropenic did not adversely affect the survival.